Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001763955 | SCV002000188 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002544139 | SCV003452730 | benign | Spastic paraplegia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002540501 | SCV003720766 | uncertain significance | Inborn genetic diseases | 2022-04-14 | criteria provided, single submitter | clinical testing | The c.2830A>T (p.R944W) alteration is located in exon 19 (coding exon 19) of the KDM5C gene. This alteration results from a A to T substitution at nucleotide position 2830, causing the arginine (R) at amino acid position 944 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |